Tag: Immuno
-
ImmunoPrecise (IPA.V): when scientific breakthrough is executed strategically
You know what grinds my gears? The fact that investors will happily speculate on Tesla (TSLA.NYSE) stock because they think they understand the automobile market, but won’t attempt to do the due diligence for biotechs because it’s “too hard”.